See every side of every news story
Published loading...Updated

HomeStreet: Q2 Earnings Snapshot

GLOBAL, JUL 29 – Revvity beat Q2 revenue and earnings estimates with 3% organic growth and raised full-year revenue guidance to $2.84 billion–$2.88 billion, driven by life sciences and diagnostics divisions.

  • Revvity reported second-quarter 2025 GAAP revenue of $720 million and adjusted EPS of $1.18, exceeding analyst estimates.
  • Management promptly adjusted manufacturing operations to reduce the anticipated $135 million tariff impact in fiscal year 2025.
  • Life Sciences and Diagnostics revenue grew 5% and 3% respectively, while the Signals software business showed over 20% organic growth in Q2.
  • The company’s operating margin calculated according to GAAP increased slightly by 0.2 percentage points to 12.6%, while the adjusted operating margin declined by 2.2 percentage points to 26.6%.
  • Revvity raised its full-year revenue guidance slightly to $2.84–2.88 billion but trimmed adjusted EPS guidance to $4.85–4.95, reflecting cost pressures and tariff uncertainties.
Insights by Ground AI
Does this summary seem wrong?

19 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 44% of the sources lean Left, 44% of the sources are Center
44% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Eagle-Tribune broke the news in on Monday, July 28, 2025.
Sources are mostly out of (0)